Integrated BioPharma Statistics
Total Valuation
INBP has a market cap or net worth of 6.55 million. The enterprise value is 4.07 million.
| Market Cap | 6.55M |
| Enterprise Value | 4.07M |
Important Dates
The next estimated earnings date is Tuesday, May 19, 2026.
| Earnings Date | May 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INBP has 31.06 million shares outstanding. The number of shares has decreased by -1.92% in one year.
| Current Share Class | 31.06M |
| Shares Outstanding | 31.06M |
| Shares Change (YoY) | -1.92% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 57.99% |
| Owned by Institutions (%) | 0.06% |
| Float | 7.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| PB Ratio | 0.35 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | 2.31 |
| P/OCF Ratio | 2.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 69.04, with an EV/FCF ratio of 1.43.
| EV / Earnings | -2.46 |
| EV / Sales | 0.08 |
| EV / EBITDA | 69.04 |
| EV / EBIT | n/a |
| EV / FCF | 1.43 |
Financial Position
The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.25 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 56.71 |
| Debt / FCF | 1.18 |
| Interest Coverage | -27.11 |
Financial Efficiency
Return on equity (ROE) is -8.40% and return on invested capital (ROIC) is -7.93%.
| Return on Equity (ROE) | -8.40% |
| Return on Assets (ROA) | -2.98% |
| Return on Invested Capital (ROIC) | -7.93% |
| Return on Capital Employed (ROCE) | -5.90% |
| Weighted Average Cost of Capital (WACC) | 4.69% |
| Revenue Per Employee | 315,366 |
| Profits Per Employee | -10,810 |
| Employee Count | 153 |
| Asset Turnover | 1.84 |
| Inventory Turnover | 5.06 |
Taxes
In the past 12 months, INBP has paid 536,000 in taxes.
| Income Tax | 536,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.07% in the last 52 weeks. The beta is 0.42, so INBP's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -27.07% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.30 |
| Relative Strength Index (RSI) | 28.55 |
| Average Volume (20 Days) | 12,826 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, INBP had revenue of 48.25 million and -1.65 million in losses. Loss per share was -0.05.
| Revenue | 48.25M |
| Gross Profit | 2.24M |
| Operating Income | -1.25M |
| Pretax Income | -1.12M |
| Net Income | -1.65M |
| EBITDA | -953,000 |
| EBIT | -1.25M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 5.83 million in cash and 3.35 million in debt, with a net cash position of 2.48 million or 0.08 per share.
| Cash & Cash Equivalents | 5.83M |
| Total Debt | 3.35M |
| Net Cash | 2.48M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 18.98M |
| Book Value Per Share | 0.61 |
| Working Capital | 12.45M |
Cash Flow
In the last 12 months, operating cash flow was 3.03 million and capital expenditures -187,000, giving a free cash flow of 2.84 million.
| Operating Cash Flow | 3.03M |
| Capital Expenditures | -187,000 |
| Depreciation & Amortization | 294,000 |
| Net Borrowing | -34,000 |
| Free Cash Flow | 2.84M |
| FCF Per Share | 0.09 |
Margins
Gross margin is 4.64%, with operating and profit margins of -2.58% and -3.43%.
| Gross Margin | 4.64% |
| Operating Margin | -2.58% |
| Pretax Margin | -2.32% |
| Profit Margin | -3.43% |
| EBITDA Margin | -1.98% |
| EBIT Margin | -2.58% |
| FCF Margin | 5.88% |
Dividends & Yields
INBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.92% |
| Shareholder Yield | 1.92% |
| Earnings Yield | -25.24% |
| FCF Yield | 43.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 2, 1996. It was a reverse split with a ratio of 0.25.
| Last Split Date | Jul 2, 1996 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |